24 September 2025
: Case report 
Management of Cesarean Section Uterine Scar Ectopic Pregnancy Type 2 Using Methotrexate: Insights from a Case Report
Unusual or unexpected effect of treatment
Taylor Pigg BCDEF 1*, Susan Fields BCDEF 1, Amalia Brawley BCDEF 1,2,3, R. Paul Roddenberry E 4, Padmashree C. Woodham
BCDEF 1,2,3
DOI: 10.12659/AJCR.948357
Am J Case Rep 2025; 26:e948357
Figure 3 Post-treatment trans-vaginal ultrasound: Trans-vaginal ultrasound image obtained from outside provider 27 days after the ultrasound-guided methotrexate injection into the gestational sac. An intra-gestational sac is not visualized on this ultrasound, indicating continued resolution of the cesarean section scar ectopic pregnancy.